Your browser doesn't support javascript.
loading
Evaluation of the 6-item Identify Chronic Migraine screener in a large medical group.
Pavlovic, Jelena M; Yu, Justin S; Silberstein, Stephen D; Reed, Michael L; Cowan, Robert P; Dabbous, Firas; Pulicharam, Riya; Viswanathan, Hema N; Lipton, Richard B.
Afiliação
  • Pavlovic JM; Department of Neurology, Montefiore Medical Center, Bronx, NY, USA.
  • Yu JS; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Silberstein SD; Allergan, an AbbVie Company, Irvine, CA, USA.
  • Reed ML; Jefferson Headache Center, Philadelphia, PA, USA.
  • Cowan RP; Vedanta Research, Chapel Hill, NC, USA.
  • Dabbous F; Stanford University School of Medicine, Stanford, CA, USA.
  • Pulicharam R; Imax Analytics, Highland Park, IL, USA.
  • Viswanathan HN; DaVita Medical Group, El Segundo, CA, USA.
  • Lipton RB; Allergan, an AbbVie Company, Irvine, CA, USA.
Headache ; 61(2): 335-342, 2021 02.
Article em En | MEDLINE | ID: mdl-33421098
OBJECTIVE: To evaluate the sensitivity and specificity of the 6-item Identify Chronic Migraine screener (ID-CM[6]), designed to improve the detection of chronic migraine (CM). BACKGROUND: CM is often undertreated and underdiagnosed. Survey-based studies have found that approximately 75-80% of people meeting criteria for CM do not report having received an accurate diagnosis. METHODS: This study used claims data of patients enrolled in a large medical group who had at least one medical claim with an International Classification of Diseases 9th/10th revision diagnostic code for migraine in the 12-month prescreening period. The Identify Chronic Migraine survey was administered by e-mail, in-person, or over the telephone to all enrolled patients. A Semi-Structured Diagnostic Interview (SSDI) was administered by telephone by a trained physician. The ID-CM(6) and SSDI classifications of CM status were compared to evaluate sensitivity and specificity of the ID-CM(6) screening tool. RESULTS: The analysis of the ID-CM(6) screening tool included 109 patients, with 65/109 (59.6%) positive for CM based on the SSDI. The mean (standard deviation) age of the patient sample was 49 (15) years and 100/109 (91.7%) were female. Using the SSDI as the diagnostic gold standard, the ID-CM(6) had a sensitivity of 70.8% (46/65) and a specificity of 93.2% (41/44). CONCLUSION: The ID-CM(6) demonstrated acceptable sensitivity and good specificity in determining CM status. The results of this analysis support the real-world utility of the ID-CM(6) as a simple and useful tool to identify patients with CM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Técnicas de Diagnóstico Neurológico / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Headache Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Técnicas de Diagnóstico Neurológico / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Headache Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos